TWST
Twist Bioscience Corporation
Stock
$188.67+0.62 (+0.33%)Close Oct 2, 2026
Cash flow statement
| Line | Last 12 months | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | −$53M | −$48M | −$64M | −$142M | −$124M | −$112M | −$142M | −$88M | −$66M | −$51M |
| Capital expenditures | $40M | $28M | $5.1M | $28M | $102M | $27M | $9.9M | $15M | $3.7M | $6.6M |
| Free cash flow | −$93M | −$76M | −$69M | −$170M | −$226M | −$139M | −$152M | −$103M | −$70M | −$58M |
| Stock-based compensation | $66M | $64M | $51M | $30M | $80M | $37M | $17M | $11M | $3.0M | $1.9M |
| Free cash flow margin | −21.6% | −20.1% | −22.1% | −69.5% | −111.1% | −105.3% | −168.8% | −188.8% | −274.7% | −537.7% |